Tena Rosser

3.2k total citations
43 papers, 1.1k citations indexed

About

Tena Rosser is a scholar working on Neurology, Epidemiology and Molecular Biology. According to data from OpenAlex, Tena Rosser has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 13 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Tena Rosser's work include Neurofibromatosis and Schwannoma Cases (23 papers), Meningioma and schwannoma management (11 papers) and Vascular Malformations Diagnosis and Treatment (9 papers). Tena Rosser is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (23 papers), Meningioma and schwannoma management (11 papers) and Vascular Malformations Diagnosis and Treatment (9 papers). Tena Rosser collaborates with scholars based in United States, Australia and Austria. Tena Rosser's co-authors include Roger J. Packer, Gilbert Vézina, Ashok Panigrahy, Carrie E. Bearden, W. McClintock, Alcino J. Silva, Maria T. Acosta, Scott R. Plotkin, Katherine H. Karlsgodt and Nicole J. Ullrich and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Tena Rosser

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tena Rosser United States 19 597 266 233 185 163 43 1.1k
Cynthia Campen United States 10 925 1.5× 217 0.8× 161 0.7× 314 1.7× 63 0.4× 19 1.2k
Alyssa Reddy United States 22 449 0.8× 204 0.8× 609 2.6× 151 0.8× 54 0.3× 58 1.4k
Paolo Galluzzi Italy 25 212 0.4× 150 0.6× 272 1.2× 140 0.8× 100 0.6× 110 1.5k
Robert C. Dauser United States 25 374 0.6× 117 0.4× 262 1.1× 227 1.2× 146 0.9× 60 1.6k
Nicholas Higgins United Kingdom 21 943 1.6× 156 0.6× 90 0.4× 174 0.9× 74 0.5× 73 1.7k
Mie‐Jef Descheemaeker Belgium 16 596 1.0× 277 1.0× 235 1.0× 337 1.8× 91 0.6× 20 989
S. Tokiguchi Japan 19 568 1.0× 94 0.4× 546 2.3× 132 0.7× 170 1.0× 50 1.5k
Elizabeth K. Schorry United States 27 1.3k 2.2× 597 2.2× 516 2.2× 471 2.5× 379 2.3× 67 2.3k
Maila Penttinen Finland 19 219 0.4× 128 0.5× 383 1.6× 173 0.9× 151 0.9× 31 920
Anna Maria Buccoliero Italy 20 122 0.2× 278 1.0× 346 1.5× 88 0.5× 120 0.7× 62 1.1k

Countries citing papers authored by Tena Rosser

Since Specialization
Citations

This map shows the geographic impact of Tena Rosser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tena Rosser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tena Rosser more than expected).

Fields of papers citing papers by Tena Rosser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tena Rosser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tena Rosser. The network helps show where Tena Rosser may publish in the future.

Co-authorship network of co-authors of Tena Rosser

This figure shows the co-authorship network connecting the top 25 collaborators of Tena Rosser. A scholar is included among the top collaborators of Tena Rosser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tena Rosser. Tena Rosser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosser, Tena. (2024). Incontinentia pigmenti. Seminars in Pediatric Neurology. 51. 101156–101156.
2.
Cannon, Ashley, Kavita Y. Sarin, Andrea Petersen, et al.. (2023). Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials. Clinical Trials. 21(1). 67–72.
3.
Merker, Vanessa L., Pamela L. Wolters, Frank D. Buono, et al.. (2023). Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials. Clinical Trials. 21(1). 6–17. 2 indexed citations
4.
Rosser, Tena, et al.. (2023). A Case of Pediatric Guillain-Barré Syndrome After Respiratory Syncytial Virus Infection. Pediatric Neurology. 146. 129–131. 2 indexed citations
5.
Cannon, Ashley, Dominique C. Pichard, Pamela L. Wolters, et al.. (2021). Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas. Neurology. 97(7_Supplement_1). S15–S24. 8 indexed citations
6.
Janusz, Jennifer, Bonnie Klein-Tasman, Jonathan M. Payne, et al.. (2021). Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1. Neurology. 97(7_Supplement_1). S73–S80. 5 indexed citations
7.
Klesse, Laura J., Justin T. Jordan, Heather B. Radtke, et al.. (2020). The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities. The Oncologist. 25(7). e1109–e1116. 65 indexed citations
8.
Kaneko, Maki, Tena Rosser, & Gordana Raca. (2020). Dilated cardiomyopathy in a patient with autosomal dominant EEF1A2-related neurodevelopmental disorder. European Journal of Medical Genetics. 64(1). 104121–104121. 3 indexed citations
9.
Plotkin, Scott R., Dan G. Duda, Alona Muzikansky, et al.. (2019). Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. Journal of Clinical Oncology. 37(35). 3446–3454. 74 indexed citations
10.
Montojo, Caroline A., Kristen M. Haut, Katherine H. Karlsgodt, et al.. (2017). Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity. NeuroImage Clinical. 15. 801–811. 18 indexed citations
11.
Wisnowski, Jessica L., Vincent J. Schmithorst, Tena Rosser, et al.. (2014). Magnetic resonance spectroscopy markers of axons and astrogliosis in relation to specific features of white matter injury in preterm infants. Neuroradiology. 56(9). 771–779. 20 indexed citations
12.
Karlsgodt, Katherine H., Tena Rosser, Evan S. Lutkenhoff, et al.. (2012). Alterations in White Matter Microstructure in Neurofibromatosis-1. PLoS ONE. 7(10). e47854–e47854. 59 indexed citations
13.
Kinney, Hannah C., Stefan Blüml, C. Jane Tavaré, et al.. (2010). Abnormal Microstructure of the Atrophic Thalamus in Preterm Survivors with Periventricular Leukomalacia. American Journal of Neuroradiology. 32(1). 185–191. 46 indexed citations
14.
Rosser, Tena, et al.. (2010). Transient Leukoencephalopathy Associated With X-Linked Charcot-Marie-Tooth Disease. Journal of Child Neurology. 25(8). 1013–1016. 16 indexed citations
15.
Rosser, Tena, et al.. (2006). Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma. Pediatric Blood & Cancer. 50(3). 699–700. 6 indexed citations
16.
Rosser, Tena. (2003). Seminar citations: Aicardi syndrome. JAMA Neurology. 60(6). 1 indexed citations
17.
Rosser, Tena. (2003). Aicardi Syndrome. Archives of Neurology. 60(10). 1471–1471. 10 indexed citations
18.
Rosser, Tena & Roger J. Packer. (2003). Neurocognitive dysfunction in children with neurofibromatosis type 1. Current Neurology and Neuroscience Reports. 3(2). 129–136. 51 indexed citations
19.
Packer, Roger J. & Tena Rosser. (2002). Therapy for plexiform neurofibromas in children with neurofibromatosis 1: an overview. Journal of Pediatric Hematology/Oncology. 24(5).
20.
Rosser, Tena, Maria T. Acosta, & Roger J. Packer. (2002). Aicardi syndrome: spectrum of disease and long-term prognosis in 77 females. Pediatric Neurology. 27(5). 343–346. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cynthia Campen Breakdown of academic impact, for papers by Alyssa Reddy Breakdown of academic impact, for papers by Paolo Galluzzi Breakdown of academic impact, for papers by Robert C. Dauser Breakdown of academic impact, for papers by Nicholas Higgins Breakdown of academic impact, for papers by Mie‐Jef Descheemaeker Breakdown of academic impact, for papers by S. Tokiguchi Breakdown of academic impact, for papers by Elizabeth K. Schorry Breakdown of academic impact, for papers by Maila Penttinen Breakdown of academic impact, for papers by Anna Maria Buccoliero
Rankless by CCL
2026